May 6th 2024
Disparities in health care systems around the world limit access to effective treatments for advanced breast cancer, especially for people in low- and middle-income countries and marginalized communities. Stronger health systems and social education efforts are necessary to improve outcomes for all patients.
Study Shows Paclitaxel, Carboplatin Effective Against Triple-Negative Breast Cancer
August 18th 2020The Adjuvant Platinum and Taxane in Triple-Negative Breast Cancer trial investigated this combination adjuvant treatment vs the standard-of-care anthracycline plus docetaxel among patients with operable disease.
Read More
Screening for Breast Cancer at Younger Ages Linked to Reduced Mortality
August 14th 2020Screening women aged 40 to 49 years for breast cancer reduced mortality by 25% in the first 10 years compared with waiting until at age 50 years and older, which is the common practice in the United Kingdom.
Read More
Are There Benefits to Awake Breast Cancer Surgery During COVID-19?
August 11th 2020In Italy, a study looked at reallocating resources meant for patients with breast cancer to those stricken with coronavirus disease 2019, finding that the former could benefit from fast-track awake surgery to reduce risk of cross-infection.
Read More
Survival Consistent for Women With Early-Stage Breast Cancer Despite Surgery Delays
August 7th 2020Delays in surgery to treat early-stage breast cancer and receiving neoadjuvant endocrine therapy did not decrease survival odds among female patients, authors report in the Journal of the American College of Surgeons.
Read More
Mortality Among Men With Breast Cancer Decreases With Adjuvant Chemotherapy
July 30th 2020Less than 1% of all breast cancers occur in men, making this a rare disease among that patient population, and most treatment guidelines are based on outcomes and survival rates seen in women with the disease.
Read More
Women With Extremely Dense Breast Tissue May Not Benefit From 3-D Mammography
July 28th 2020Compared with digital mammography, digital breast tomosynthesis, also called 3-dimensional (3-D) mammography, has been proven superior at effectively detecting breast cancer and leading to fewer recall visits, but more information is needed for how subgroups of women with different breast densities benefit from the screening method, especially those classified as having extremely dense breast tissue.
Read More
Germline BRCA-Mutated Breast Cancer Does Not Increase Risk of Adverse Pregnancy Outcomes
July 23rd 2020Women with early-onset germline BRCA-mutated breast cancer can have subsequent pregnancies without increasing their risk for disease recurrence, according to the authors of a recent study in Journal of Clinical Oncology.
Read More
Diagnostic Delays From COVID-19 May Increase Cancer-Related Deaths, UK Studies Say
July 21st 2020The next several years could bear witness to thousands of additional deaths from cancer that could have been prevented through routine diagnostic care that was delayed because of the coronavirus disease 2019 (COVID-19) pandemic, according to a pair of studies in The Lancet Oncology.
Read More